IP Library Granted Patent US 12686884
Granted Patent B2
US 12686884 · App. 18/312,914 · Granted Jul 21, 2026

Compositions, systems and methods for CRISPR-based enzyme optimization

Inventor: Michael Gibbons (Pleasanton, CA)
Assignee: 10x Genomics, Inc.
C12Q1/485C12N9/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12686884
App. No.
18/312,914
Granted
Jul 21, 2026
Kind
B2
Abstract

Provided herein are reaction mixtures, compositions, systems, methods, and kits for assessing enzymatic activity. Aspects of the disclosure include use of a reactant barcoded oligonucleotide (RBO) construct comprising a first oligonucleotide comprising a reaction barcode sequence and a first linker that connects the first oligonucleotide to a first reactant, an amplification construct comprising a second oligonucleotide that is complementary to at least a portion of the first oligonucleotide and a second linker that connects the second oligonucleotide to a second reactant, and a blocking construct, comprising a third oligonucleotide that is complementary to at least a portion of the first oligonucleotide. A rate of reaction product generation may be measured to determine an enzymatic activity of a given enzyme.

Claims (35)

1 . A method for assessing enzymatic activity, the method comprising: combining a reactant barcoded oligonucleotide (RBO) construct with an amplification construct, a blocking construct, and an enzyme in a reaction mixture, wherein the reactant barcoded oligonucleotide (RBO) construct comprises:

a first oligonucleotide comprising a reaction barcode sequence; and a first linker that connects the first oligonucleotide to a first reactant;

wherein the amplification construct comprises:

a second oligonucleotide that is complementary to at least a portion of the first oligonucleotide; and

a second linker that connects the second oligonucleotide to a second reactant; and

wherein the blocking construct comprises:

a third oligonucleotide that is complementary to at least a portion of the first oligonucleotide;

enzymatically reacting the first reactant with the second reactant to produce a reaction product;

restricting movement of the amplification construct relative to the RBO construct; and

generating a reverse complement of the reaction barcode sequence with an amplification enzyme.

2 . The method of claim 1 , wherein generating a reverse complement of the reaction barcode sequence with an amplification enzyme comprises conducting an amplification reaction on the first oligonucleotide comprising the reaction barcode sequence to produce an extension product.

3 . The method of claim 2 , wherein the amplification reaction comprises the step of annealing a second adapter to a second adapter binding site adjacent to a 3′ end of the reaction barcode sequence and generating a reverse complement of the reaction barcode sequence.

4 . The method of claim 3 , wherein the step of annealing further comprises annealing a first adapter to a first adapter binding site adjacent to a 5′ end of the barcode sequence.

5 . The method according to claim 2 , wherein the amplification enzyme comprises a polymerase.

6 . The method according to claim 2 , wherein the amplification enzyme comprises a reverse transcriptase.

7 . The method according to claim 1 , further comprising:

assessing an enzymatic activity of an enzyme based on an amplification product of the amplification reaction.

8 . The method of claim 7 , wherein the amplification product is detectable.

9 . The method of claim 7 , wherein the amplification product comprises a detectable label.

10 . The method of claim 7 , wherein the amplification product encodes a detectable label.

11 . The method according to claim 2 , further comprising:

identifying the enzyme using the reaction barcode sequence.

12 . The method according to claim 2 , further comprising:

modifying an amino acid sequence of the enzyme.

13 . The method of claim 12 , wherein the step of modifying occurs before combining the reactant barcoded oligonucleotide (RBO) construct with the amplification construct, the blocking construct, and the enzyme in the reaction mixture.

14 . The method according claim 12 , wherein modifying an amino acid sequence of the enzyme comprises a CRISPR-mediated amino acid sequence modification.

15 . The method according to claim 1 , wherein the first and second reactants each comprise a protein.

16 . The method according to claim 1 , wherein the first and second reactants each comprise a polynucleotide.

17 . The method according to claim 1 , further comprising:

increasing an affinity between the RBO construct and the blocking construct.

18 . The method according to claim 1 , wherein the second oligonucleotide comprises at least one LNA.

19 . The method according to claim 1 , wherein the portion of the first oligonucleotide that is complementary to the second oligonucleotide comprises at least one LNA.

20 . The method according to claim 1 , wherein the second oligonucleotide comprises a non-reactive 3′ end.

21 . The method according to claim 1 , wherein the reaction product comprises the first reactant covalently linked to the second reactant.

22 . The method according to claim 1 , wherein a quantity of the blocking construct is greater than a quantity of the amplification construct.